Suppr超能文献

基于KDIGO分类的早期启动连续性肾脏替代治疗对急性肾损伤危重症患者预后的影响

[Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].

作者信息

Chen Minhua, Hu Bangchuan, Li Qian, Liu Jingguan

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Mar;28(3):246-51.

Abstract

OBJECTIVE

To investigate the impact of early initiation of continuous renal replacement therapy (CRRT) based on "Kidney Disease: Improving Global Outcomes (KDIGO)" classification on the prognosis of critically ill patients with acute kidney injury (AKI).

METHODS

A retrospective analysis of clinical data of patients diagnosed as AKI in Department of Critical Care Medicine of Zhejiang Provincial People's Hospital from January 2011 to January 2015 was conducted. All patients included should be 18 years old or older, having stayed in intensive care unit (ICU) for more than 48 hours, and received CRRT. All subjects were divided into three groups according to their renal function before CRRT according to the KDIGO-AKI guideline: AKI-stage 1 group, AKI-stage 2 group and AKI-stage 3 group. The general condition, original disease, severity of disease, duration of mechanical ventilation, the length of ICU or hospital stay, 28-day survival rate and in-hospital mortality rate were compared among these three groups. Additionally, risk factors for the 28-day survival rate and hospital mortality of critically ill patients with AKI were screened by logistic regression analysis.

RESULTS

A total of 258 critically ill patients with AKI were enrolled, with 64 cases in AKI-stage 1 group, 62 cases in AKI-stage 2 group, and 132 cases in AKI-stage 3 group. 116 patients survived with 28-day survival rate of 44.96%. 154 patients died with hospital mortality 59.69%. The precipitating factors of AKI in all three groups (stage 1, stage 2, and stage 3) were similar, with sepsis, heart failure and poisoning (drugs or poison) being the main triggers for AKI, accounting for 35.66%, 19.38% and 13.18%, respectively. There were significant differences in the rate of vasoactive agent usage (31.25%, 41.94%, 50.00%, χ2 = 6.241, P = 0.044), acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) score (20.87±7.37, 17.19±7.02, 22.58±7.95, F = 5.292, P = 0.006) and sequential organ failure assessment (SOFA) score (8.41±3.46, 6.22±2.43, 9.58±3.71, F = 10.328, P = 0.000), while there was no significant difference in gender, age, primary disease, time from ICU admission to the beginning of CRRT, mean arterial pressure (MAP), lactate level or 24-hour lactate clearance rate (LCR), mechanical ventilation time, the length of ICU or hospital stay, 28-day survival rate or hospital mortality among these three groups (all P > 0.05). According to the logistic regression analysis, time from ICU admission to start of CRRT and lactate level were the independent risk factors for 28-day survival rate or hospital mortality of critically ill patients with AKI [odds ratio (OR) for 28-day survival rate was 0.850 and 0.774, 95% confidence interval (95%CI) was 0.752-0.960 and 0.638-0.940, P value was 0.009 and 0.010, respectively; OR for hospital mortality was 0.884 and 0.756, 95%CI was 0.781-1.000 and 0.610-0.939, P value was 0.049 and 0.011, respectively].

CONCLUSION

Early initiation of CRRT based on KDIGO-AKI classification could not improve the prognosis of critically ill patients with AKI, the optimal timing of RRT for such patients remains to be further explored.

摘要

目的

探讨基于“改善全球肾脏病预后(KDIGO)”分类的早期开始连续性肾脏替代治疗(CRRT)对急性肾损伤(AKI)危重症患者预后的影响。

方法

对2011年1月至2015年1月浙江省人民医院重症医学科诊断为AKI的患者临床资料进行回顾性分析。纳入的所有患者年龄应在18岁及以上,在重症监护病房(ICU)停留超过48小时,并接受了CRRT。所有受试者根据KDIGO-AKI指南,在CRRT前根据肾功能分为三组:AKI 1期组、AKI 2期组和AKI 3期组。比较这三组患者的一般情况、原发病、疾病严重程度、机械通气时间、ICU或住院时间、28天生存率和住院死亡率。此外,通过逻辑回归分析筛选AKI危重症患者28天生存率和医院死亡率的危险因素。

结果

共纳入258例AKI危重症患者,其中AKI 1期组64例,AKI 2期组62例,AKI 3期组132例。116例患者存活,28天生存率为44.96%。154例患者死亡,住院死亡率为59.69%。三组(1期、2期和3期)AKI的诱发因素相似,脓毒症、心力衰竭和中毒(药物或毒物)是AKI的主要触发因素,分别占35.66%、19.38%和13.18%。血管活性药物使用率(31.25%、41.94%、50.00%,χ2 = 6.241,P = 0.044)、急性生理与慢性健康状况评分Ⅱ(APACHEⅡ)(20.87±7.37、17.19±7.02、22.58±7.95,F = 5.292,P = 0.006)和序贯器官衰竭评估(SOFA)评分(8.41±3.46、6.22±2.43、9.58±3.71,F = 10.328,P = 0.000)存在显著差异,而三组在性别、年龄、原发病、从入住ICU到开始CRRT的时间、平均动脉压(MAP)、乳酸水平或24小时乳酸清除率(LCR)、机械通气时间、ICU或住院时间、28天生存率或住院死亡率方面均无显著差异(均P > 0.05)。根据逻辑回归分析,从入住ICU到开始CRRT的时间和乳酸水平是AKI危重症患者28天生存率或医院死亡率的独立危险因素[28天生存率的比值比(OR)分别为0.850和0.774,95%置信区间(95%CI)为0.752 - 0.960和0.638 - 0.940,P值分别为0.009和0.010;住院死亡率的OR分别为0.884和0.756,95%CI为0.781 - 1.000和0.610 - 0.939,P值分别为0.049和0.011]。

结论

基于KDIGO-AKI分类的早期开始CRRT不能改善AKI危重症患者的预后,此类患者肾脏替代治疗的最佳时机仍有待进一步探索。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验